Growth Metrics

Armata Pharmaceuticals (ARMP) Payables (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Payables for 6 consecutive years, with $714000.0 as the latest value for Q3 2018.

  • Quarterly Payables fell 44.74% to $714000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $714000.0 through Sep 2018, down 44.74% year-over-year, with the annual reading at $340000.0 for FY2017, 90.49% down from the prior year.
  • Payables hit $714000.0 in Q3 2018 for Armata Pharmaceuticals, up from $682000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $3.6 million in Q4 2016 to a low of $340000.0 in Q4 2017.
  • Historically, Payables has averaged $1.7 million across 5 years, with a median of $1.5 million in 2015.
  • Biggest five-year swings in Payables: skyrocketed 153.26% in 2016 and later crashed 90.49% in 2017.
  • Year by year, Payables stood at $1.2 million in 2014, then increased by 20.99% to $1.4 million in 2015, then surged by 153.26% to $3.6 million in 2016, then plummeted by 90.49% to $340000.0 in 2017, then soared by 110.0% to $714000.0 in 2018.
  • Business Quant data shows Payables for ARMP at $714000.0 in Q3 2018, $682000.0 in Q2 2018, and $810000.0 in Q1 2018.